News

04/08/2010	Director & PDMR Shareholding
03/08/2010	Partner Funded Programme Update
17/06/2010	AGM Statement
14/06/2010	Director/PDMR Shareholding
19/05/2010	Notice of AGM
18/05/2010	Directors Transfer of Shares
06/05/2010	Preliminary Results
04/05/2010	Notice of results
30/03/2010	Research Update
05/03/2010	Director and PDMR Share Dealings
24/02/2010	Trading Update
12/01/2010	Research Update
30/12/2009	Result of GM
30/12/2009	Results of firm placing and open offer
02/11/2009	Director/PDMR Shareholding
30/10/2009	Director/PDMR Shareholding
29/10/2009	Director/PDMR Shareholding: Grant of Options
28/10/2009	Director/PDMR Shareholding
23/10/2009	Interim Results for the Six Months Ended 31 July 2009
21/10/2009	Notice of Interim Results
02/09/2009	Divestment of Dextra Services Business To New Zealand Pharmaceuticals
21/08/2009	Result of AGM
29/07/2009	Announcement of AGM
28/07/2009	Preliminary Results
07/05/2009	Disposal of Zebrafish Business
20/02/2009	Update on Financial Position
23/01/2009	Directorate change
06/01/2009	Evolva Licensing Agreement
28/10/2008	Directorate Change

Summit Corporation plc (AIM:SUMM)

Leading UK biotechnology company that is focused on discovering and developing proprietary new drugs to treat serious diseases where there is currently a high and unmet medical need.

http://www.summitplc.com

Should you require any further information,
please contact:

Paul Dulieu
Account Director, City & Corporate
Tel: 020 7566 6700
Email: pd@redleafpr.com

Henny Irwin
Retail IR
Tel: 020 7566 6742
Email: hi@redleafpr.com